PerkinElmer and Scitara join forces to create tech-driven ‘model of the modern lab’

Both companies will integrate their products to improve data management and automation in a laboratory setting
Analytical technology leader PerkinElmer and cloud-based software provider Scitara have announced a collaboration that combines their product offerings to create a ‘model of the modern lab’.
The move will see PerkinElmer integrate its Signals Research Suite informatics platform with Scitara’s Scientific Integration Platform (SIP) to create a fully connected laboratory with enhanced data management and automation capabilities.
PerkinElmer’s Signals Research Suite provides end-to-end scientific data and workflow management, while Scitara’s SIP provides a universal connectivity solution in a cloud native infrastructure. The deal aligns with PerkinElmer’s strategy of using its informatics offerings to drive digital transformation in the lab.
Scitara’s CEO Ajit Nagral said the agile framework offered by the collaboration guarantees flexibility as standard.
‘It provides the ability to extract maximum value from legacy equipment, while dramatically lowering the barrier to introduce new, innovative technology into the connected lab. We drive data aggregation to any selected customer repository in an agile, compliant and future-proof solution.
A breakthrough level of automation – from the simplest to the most complex tasks – is achieved while complying with the most stringent requirements of regulated markets,' he said.
Earlier this year Scitara raised $15 million in Series B funding, which analysts say was fuelled by the success of its SIP.
Speaking about the collaboration, Kevin Willoe, VP and General Manager, Informatics at PerkinElmer, said merging the two services will create a ‘truly integrated laboratory environment.’
‘This will help tie together instruments, software and systems and support our customers in curating data in a standardized platform. This is the power of the lab of the future in action,’ he said.
Both companies say integrating the SIP infrastructure with the PerkinElmer Signals Research platform will allow for improved data management, enhanced collaboration and more lab automation. Integrated data science can be used in tandem with AI and analytic tools, providing scientists with faster insights, fuelling decision making and ultimately accelerating products to market.
Related News
-
News How GLP-1 agonists are reshaping drug delivery innovations
GLP-1 agonist drug products like Ozempic, Wegovy, and Mounjaro have taken the healthcare industry by storm in recent years. Originally conceived as treatment for Type 2 diabetes, the weight-loss effects of these products have taken on unprecedented int... -
News 2025 Pharma Trends Outlook: Collaborative Pharma – A New Era of Supply Chains
A new year, a new Pharma Trends Outlook report! The 2025 Pharma Trends Outlook report examines key changes expected in the pharmaceutical industry for the coming year, particularly in regards to the supply chain. -
News AI-driven drug discovery model sets new accuracy prediction benchmark
Iambic Therapeutics, an Nvidia-backed biotech based in London, have stated that their AI drug discovery model named ‘Enchant’ demonstrates the potential to reduce the time and cost associated with new drug development. -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News Viral marketing for B2B pharma businesses: a CPHI Online case study
Discover how a Chinese chemical manufacturing company went viral on TikTok, and what their viral success means for the future of B2B digital marketing for the wider pharmaceutical industry and supply chain. -
News Sanofi to collaborate with OpenAI and Formation Bio
Pharmaceutical giant Sanofi have announced a collaboration with Formation Bio and OpenAI to build AI-powered software for accelerated drug development. -
News CPHI Online Webinar Series – Optimising Pharma Manufacturing through Digital Transformations
This month’s CPHI Webinar Series explored achieving manufacturing excellence in pharma through the digitalisation of daily processes. Presented by Joe Doyle, Head of Sales at EviView, and Bikash Chatterjee, President and Chief Scientific Off... -
News Western pharma groups warn of supply disruptions over China anti-spy law
China’s anti-espionage laws have caused concern among western pharmaceutical groups over potential arrests or denial of access for foreign inspectors in China-based facilities and manufacturing partners, posing a risk to the supply of drug produc...
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance